Literature DB >> 17100553

The leading edge of stem cell therapeutics.

Ilyas Singec1, Rahul Jandial, Andrew Crain, Guido Nikkhah, Evan Y Snyder.   

Abstract

Stem cells, by virtue of their defining property of self-renewal, represent an unlimited source of potentially functional human cells for basic research and regenerative medicine. Having validated the feasibility of cell-based therapeutic strategies over the past decade, mostly through the use of rodent cells, the stem cell field has now embarked upon a detailed characterization of human cells. Recent progress has included improved cell culture conditions, long-term propagation, directed differentiation, and transplantation of both human embryonic and somatic stem cells. Continued progress in understanding basic human stem cell biology, combined with a better handle on the fundamental pathophysiology of human diseases one wishes to target (including the use of human stem cells in primate and other large animal models of human disease), should help to move this technology closer to clinical application.

Entities:  

Mesh:

Year:  2007        PMID: 17100553     DOI: 10.1146/annurev.med.58.070605.115252

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  34 in total

1.  Regeneration: Thomas Hunt Morgan's window into development.

Authors:  Mary Evelyn Sunderland
Journal:  J Hist Biol       Date:  2010       Impact factor: 1.326

2.  A Foxo/Notch pathway controls myogenic differentiation and fiber type specification.

Authors:  Tadahiro Kitamura; Yukari Ido Kitamura; Yasuhiro Funahashi; Carrie J Shawber; Diego H Castrillon; Ramya Kollipara; Ronald A DePinho; Jan Kitajewski; Domenico Accili
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

3.  Resveratrol activates SIRT1 in a Lamin A-dependent manner.

Authors:  Shrestha Ghosh; Baohua Liu; Zhongjun Zhou
Journal:  Cell Cycle       Date:  2013-02-25       Impact factor: 4.534

4.  Biomimetic three-dimensional microenvironment for controlling stem cell fate.

Authors:  Hu Zhang; Sheng Dai; Jingxiu Bi; Kuo-Kang Liu
Journal:  Interface Focus       Date:  2011-07-27       Impact factor: 3.906

5.  Stem cell tracking with optically active nanoparticles.

Authors:  Yu Gao; Yan Cui; Jerry Ky Chan; Chenjie Xu
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

6.  Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants.

Authors:  Ying Jin; Karna Sura; Itzhak Fischer
Journal:  J Neurosci Res       Date:  2012-06-27       Impact factor: 4.164

7.  Amide-type local anesthetics and human mesenchymal stem cells: clinical implications for stem cell therapy.

Authors:  Ryan C Dregalla; Nicolette F Lyons; Patrick D Reischling; Christopher J Centeno
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

Review 8.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

9.  Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenes.

Authors:  Po-Yuan Tung; Natalia V Varlakhanova; Paul S Knoepfler
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

10.  The FunGenES database: a genomics resource for mouse embryonic stem cell differentiation.

Authors:  Herbert Schulz; Raivo Kolde; Priit Adler; Irène Aksoy; Konstantinos Anastassiadis; Michael Bader; Nathalie Billon; Hélène Boeuf; Pierre-Yves Bourillot; Frank Buchholz; Christian Dani; Michael Xavier Doss; Lesley Forrester; Murielle Gitton; Domingos Henrique; Jürgen Hescheler; Heinz Himmelbauer; Norbert Hübner; Efthimia Karantzali; Androniki Kretsovali; Sandra Lubitz; Laurent Pradier; Meena Rai; Jüri Reimand; Alexandra Rolletschek; Agapios Sachinidis; Pierre Savatier; Francis Stewart; Mike P Storm; Marina Trouillas; Jaak Vilo; Melanie J Welham; Johannes Winkler; Anna M Wobus; Antonis K Hatzopoulos
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.